
Scribe Therapeutics Inc.
SCTXNASDAQHealthcareBiotechnology
Previous close
$34.13
+$1.30 · +3.96%
Aug 21, 4:00 PM ET
Pre-market
$35.25
+$1.12 · +3.28%
Aug 24, 7:32 AM ET
SCTX company overview
Regular session · ET · Market data may be delayed.
Company profile
Company websiteScribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Benjamin L. Oakes
- Listed since
- Jul 24, 2026
- Employees
- 89
Market position
Day range
Current $34.13
$33.90$36.8899
52-week range
Current $34.13
$17.31$39.60
- Open
- $33.90
- Previous close
- $32.83
- Volume
- 179.58K
- 0.73× average
- Average volume
- 245.4K
- Average daily volume
- Market cap
- 552.29M USD
- Beta
- 0
- Market reference 1
- 50-day average
- $23.6085
- +44.57% above average
- 200-day average
- $23.6085
- +44.57% above average
SCTX peers
ETFs holding SCTX
Funds reporting this stock among their holdings, ordered by reported position size.
ETFMarket valueWeightAUMExpense ratioPrice / 1D
ARK Genomic Revolution ETFARKG13.29M0.64%1.56B USD0.75%$49.45—
Vanguard Morningstar Total Stock Market ETFVTI301.18K0.00%2.3T USD0.03%$378.24—
Vanguard Extended Market ETFVXF112.07K0.00%93.7B USD0.05%$245.53—
Tema Healthcare AI ETFHLTH35.72K0.77%——$29.4417—
T. Rowe Price Innovation Leaders ETFTNXT12.34K0.07%——$28.5422—
Vanguard Russell 2000 ETFVTWO9.74K0.00%17.4B USD0.06%$121.25—
ARK Genomic Revolution ETFARKG- Market value
- 13.29M
- Weight
- 0.64%
- AUM
- 1.56B USD
- Expense ratio
- 0.75%
- Price / 1D
- $49.45—
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 301.18K
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24—
Vanguard Extended Market ETFVXF- Market value
- 112.07K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53—
Tema Healthcare AI ETFHLTH- Market value
- 35.72K
- Weight
- 0.77%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $29.4417—
T. Rowe Price Innovation Leaders ETFTNXT- Market value
- 12.34K
- Weight
- 0.07%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $28.5422—
Vanguard Russell 2000 ETFVTWO- Market value
- 9.74K
- Weight
- 0.00%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25—
Continue in GoAI
Research SCTXresearch.disclaimer





